Updated Date: Fri, 07 Aug 2020 00:00:00 EDT

FiercePharmaAsia—Japan COVID-19 vax deals; Samsung Biologics’ $2B super plant; Eisai’s new U.S. HQ aliu Fri, 08/14/2020 – 08:55

Mesoblast scores FDA committee’s backing for cell therapy despite some early worries kblankenship Fri, 08/14/2020 – 09:08

UK books COVID-19 vaccine doses from J&J and Novavax and backs new clinical trials arlene.weintraub Fri, 08/14/2020 – […]

Busy AstraZeneca inks yet another big COVID vaccine deal, this time with EU esagonowsky Fri, 08/14/2020 – 09:43

UnitedHealthcare spurns Gilead’s newer PrEP drug Descovy as Truvada generic looms: report aliu Fri, 08/14/2020 – 10:28

The Center for Noise and Vibration Control at KAIST announced that their coughing detection camera recognizes where coughing […]

When hip prostheses are replaced, the old bone cement in the femur must first be removed – a […]

Company will manufacture over 25% more doses than previously planned

Clinical trial programme resumes after safety concerns